Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients

Transplantation Proceedings

Volumn 36, Issue 1, 2004, Pages 86-88

  Akbas, S H ^a,b   Yavuz, A ^a   Tuncer, M ^a   Yurdakonar, E ^a   Akcit, F ^a   Gurkan, A ^a   Demirbas, A ^a   Gultekin, M ^a   Ersoy, F ^a   Akaydin, M ^a  

^a Department of Central Laboratory ^*  (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ACCURACY; ANALYTIC METHOD; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DETERMINATION; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; HUMAN; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RELIABILITY;

EID: 0842346474     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2003.11.062     Document Type: Conference Paper

References (6)

1. Hesse C.J., Baan C.C., Balk A.H., Metselaar H.J., et al. Evaluation of the new EMIT enzyme immunoassay for the determination of whole blood tacrolimus concentrations in kidney, heart, and liver transplant patients. Transplant Proc. 34:2002;2988.
2. Dietemann J., Berthoux P., Gay-Montchamp J.P., et al. Comparison of ELISA method versus MEIA method for daily practice in the therapeutic monitoring of tacrolimus. Nephrol Dial Transplant. 16:2001;2246.
3. Christians U., Kruse C., Kownatzki R., et al. Measurement of FK 506 by HPLC and isolation and characterization of its metabolites. Transplant Proc. 23:1991;940.
4. Ghoshal A.K., Soldin S.J. Imx tacrolimus II assay is it reliable at low blood concentrations? A comparison with tandem MS/MS . Clin Chem. 35:2002;389.
5. Emit 2000 Tacrolimus Assay (package insert). Syva Company, Dade Behring Inc, Cupertino, CA, 2002.
6. Kuzuya T., Ogura Y., Motegi Y., et al. Interference of hematocrit in the tacrolimus II microparticle enzyme immunoassay. Ther Drug Monit. 24:2002;507.